Anna Schoenbach,  —

Recent Posts

• With rare diseases, not every cloud has a silver lining
• Intellia launches Phase 3 trial of gene-editing therapy NTLA-2002
• Kalvista asks 4 countries to OK sebetralstat as treatment for HAE
• Astria’s navenibart (STAR-0215) granted orphan drug status for HAE
• Life quality declines as frequency of HAE attacks rises, study finds